Bumetanide Dosing Conversion from Furosemide 40 mg
For a patient taking 40 mg oral furosemide, convert to 1 mg oral bumetanide using the standard 1:40 conversion ratio. 1
Conversion Rationale
The FDA-approved bumetanide label explicitly states that bumetanide can be substituted at approximately a 1:40 ratio in proportion to furosemide 1. This conversion is supported by:
- Guideline recommendations: The 2022 AHA/ACC/HFSA Heart Failure Guidelines list bumetanide 0.5-1.0 mg as the initial daily dose, with furosemide 20-40 mg as the comparable starting dose 2
- Clinical practice standards: The 2019 ACC Expert Consensus recommends converting outpatient oral loop diuretics to IV at 1-2.5 times the home dose, acknowledging the established dose equivalencies between agents 3
Practical Dosing Approach
Starting dose: Begin with bumetanide 1 mg orally once daily (equivalent to furosemide 40 mg)
Dosing flexibility:
- If inadequate response after initial dose, give a second or third dose at 4-5 hour intervals
- Maximum daily dose: 10 mg 1
- Most patients achieve adequate diuresis with 0.5-2 mg daily as a single dose 2, 1
Key Pharmacologic Advantages of Bumetanide
Bumetanide offers superior oral bioavailability compared to furosemide 2, which is particularly relevant since:
- Patients with heart failure have delayed and reduced absorption of both loop diuretics 4
- Bumetanide absorption is more consistent and complete than furosemide 4, 5
- The 1:40 potency ratio accounts for approximately 40-50 times greater milligram potency 5, 6, 7
Clinical Monitoring
Monitor the same parameters as with furosemide:
- Daily weights and fluid balance
- Electrolytes (particularly potassium, sodium)
- Renal function (creatinine, BUN)
- Signs of congestion resolution 2, 3
Important caveat: While some older studies suggested bumetanide may cause slightly less potassium wasting than furosemide at equivalent natriuretic doses 6, 8, this difference is not clinically significant enough to alter monitoring practices 6. Both agents require similar electrolyte surveillance.
When to Consider Bumetanide Over Furosemide
Consider bumetanide preferentially when:
- Poor response to furosemide despite adequate dosing (may indicate absorption issues) 2
- Concern for furosemide malabsorption in advanced heart failure 4
- History of furosemide-related ototoxicity (bumetanide has lower ototoxicity risk) 9
- Need for more predictable bioavailability 9, 10
Cross-sensitivity note: Bumetanide can be safely substituted in patients with furosemide allergy, as cross-sensitivity is rare 1.